Quoted message said:The local newspaper here in NJ had an article on how to avoid diabetes
for those with pre-diabetes. And here are the tips, which I think most
of us here would find quite remarkable:
1 Eat more foods that are broiled and fewer foods that are fried.
2 Cut back on the amount of butter used in cooking
3 Eat fish and chicken more, and only eat lean cuts of beef
4 Eat more meatless meals, or re-orient meals so that the dinner has
more vegetables, fruit and starches and less meat
Source for the tips was attributed to Joslin Diabetes Center
I'm not a diabetic, but from what I know about the disease, I find this
very strange, particularly #4, which advocates replacing protein with
starch?
Interesting connections:
Joslin Clinical Oversight Committee
James Rosenzweig, MD - Chairperson
Richard Beaser, MD
Elizabeth Blair, MS, CS-ANP, CDE
Patty Bonsignore, MS, RN, CDE
Amy Campbell, MS, RD, CDE
Cathy Carver, ANP, CDE
Jerry Cavallerano, OD, PhD
Sonya Celeste-Harris, MSN, RN
Om Ganda, MD
John W. Hare, MD
LuAnn Kimker, MSN, RN
Lori Laffel, MD, MPH
William Petit, MD
Evan Rosen, MD
Kristi Silver, MD
Susan Sjostrom, JD
Kenneth Snow, MD
Robert Stanton, MD
William Sullivan, MD
Howard Wolpert, MD
Martin Abrahamson, MD (ex officio)
Richard S. Beaser, M.D., Assistant Clinical Professor of Medicine,
Harvard Medical School, Medical Executive Director, Joslin Diabetes
Center, Boston, MA. Consultant to Amgen Inc., Amylin Pharmaceuticals,
Inc., and Wyeth Pharmaceuticals; member of the speakers' bureaus for
Aventis Pharmaceuticals and Wyeth Pharmaceuticals.
(http://www.medscape.com/viewprogram/3743_authors; accessed 7/28/05)
Om P. Ganda, M.D., Associate Clinical Professor of Medicine, Harvard
Medical School, Director, Joslin Diabetes Center Lipid Clinic, Boston,
MA. Received research support from KOS Pharmaceuticals, Inc.;
consultant to Merck & Co., Pfizer Inc, and Takeda Pharmaceuticals North
America, Inc.; member of the speakers' bureaus for GlaxoSmithKline,
KOS Pharmaceuticals, Inc., Merck & Co., Pfizer Inc, and Takeda
Pharmaceuticals North America, Inc.
(http://www.medscape.com/viewprogram/3743_authors; accessed 7/28/05)
Martin J. Abrahamson, M.D., Associate Professor, Harvard Medical
School, Boston, MA. Acting Chief Medical Officer, Joslin Diabetes
Center, Boston, MA. Receives research grants from Pfizer Inc.; member
of the speaker's bureaus for AstraZeneca Pharmaceuticals LP, Aventis
Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company,
GlaxoSmithKline, Merck & Co., Novo Nordisk, Novartis, Pfizer Inc, and
Takeda Pharmaceuticals North America.
(http://www.medscape.com/viewprogram/3942_authors; accessed 7/28/05)
TC